Abeona Therapeutics Inc vs ON Holding AG — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while ON Holding AG trades at $31.32 (market cap $10.33B). The key difference: ON Holding AG is far larger — about 24.5× Abeona Therapeutics Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, ON Holding AG nearer its low. Which is the better fit depends on your goals.
| ABEO | ONON | |
|---|---|---|
Market Cap | $421.19M | $10.33B |
Sector | Health | Technology |
52-Week High | $7.45 | $50.63 |
52-Week Low | $4.17 | $30.91 |
Enterprise Value | $276.10M | $9.47B |
Trailing returns across standard periods
Latest headlines on both assets
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →ON Holding AG is a Swiss sports company primarily known for its high-performance running shoes, apparel, and accessories under the 'On' brand. The company emphasizes a blend of high-end design, proprietary cloud technology (like CloudTec cushioning), and sustainability in its products. On has rapidly gained market share globally, appealing to both competitive athletes and general consumers in the performance and lifestyle footwear segments.
Read more on ONON →